Bio-Techne Corporation
TECH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,648,462 | $7,970,274 | $9,226,720 | $11,411,785 |
| - Cash | $144,962 | $162,186 | $140,670 | $177,549 |
| + Debt | $380,702 | $444,058 | $423,499 | $395,127 |
| Enterprise Value | $8,884,202 | $8,252,146 | $9,509,549 | $11,629,363 |
| Revenue | $286,555 | $316,964 | $316,181 | $297,031 |
| % Growth | -9.6% | 0.2% | 6.4% | – |
| Gross Profit | $190,191 | $198,812 | $214,556 | $193,886 |
| % Margin | 66.4% | 62.7% | 67.9% | 65.3% |
| EBITDA | $77,799 | $6,430 | $67,852 | $72,108 |
| % Margin | 27.1% | 2% | 21.5% | 24.3% |
| Net Income | $38,179 | -$17,678 | $22,588 | $34,890 |
| % Margin | 13.3% | -5.6% | 7.1% | 11.7% |
| EPS Diluted | 0.24 | -0.11 | 0.14 | 0.22 |
| % Growth | 318.2% | -178.6% | -36.4% | – |
| Operating Cash Flow | $27,585 | $98,201 | $41,120 | $84,346 |
| Capital Expenditures | -$5,363 | -$4,890 | -$10,123 | -$6,821 |
| Free Cash Flow | $22,222 | $93,311 | $30,997 | $77,525 |